Inmed announces results of second phase 1 clinical trial of inm-755 cbn cream in healthy subjects

Tsx: in nasdaq: inm vancouver, bc, jan. 8, 2021 /prnewswire/ - inmed pharmaceuticals inc. ("inmed" or the "company") (nasdaq: inm) (tsx: in), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical...

INM Ratings Summary

INM Quant Ranking